PMC:7307149 / 2678-2843 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T23","span":{"begin":118,"end":121},"obj":"Body_part"}],"attributes":[{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"Following the development of a vaccine against SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T22","span":{"begin":47,"end":55},"obj":"Disease"},{"id":"T23","span":{"begin":81,"end":89},"obj":"Disease"}],"attributes":[{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Following the development of a vaccine against SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T34","span":{"begin":29,"end":30},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T35","span":{"begin":63,"end":68},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Following the development of a vaccine against SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination."}

{"project":"LitCovid-PubTator","denotations":[{"id":"59","span":{"begin":47,"end":57},"obj":"Species"},{"id":"63","span":{"begin":81,"end":89},"obj":"Disease"}],"attributes":[{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"Tax:2697049"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Following the development of a vaccine against SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination."}

{"project":"LitCovid-sentences","denotations":[{"id":"T27","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Following the development of a vaccine against SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination."}